Blitz Bureau
THE 30th edition of the Dubai International Pharmaceuticals and Technologies Conference and Exhibition – DUPHAT 2025 concluded successfully, recording AED9.35 billion in direct and indirect trade deals over the past three days.
The event highlighted the UAE’s pivotal role as one of the world’s largest pharmaceutical and technology markets, contributing significantly to the objectives of the National Drug Policy, including a targeted market growth of 10-15 per cent within five years of its launch.
DUPHAT 2025 served as a vibrant platform uniting global and local companies, fostering innovation, creating new business opportunities, and propelling the growth of the UAE’s pharmaceutical sector in alignment with the nation’s vision for sustainable economic development.
The event attracted over 31,000 visitors from 101 countries and featured participation from 1,400 global companies in the pharmaceutical sector. Held at the Dubai World Trade Centre, the exhibition showcased the latest innovations in pharmaceuticals, healthcare, and dietary supplements, emphasising advanced solutions and technologies aimed at enhancing healthcare safety and quality.
This year’s conference included 155 expert speakers who delivered 130 scientific sessions and hosted 9 professional workshops. It also featured 400 scientific posters presented by university students highlighting cutting-edge medical research.
A notable highlight was the launch of “VitaShow Dubai,” which brought together more than 275 global brands to showcase advancements in dietary supplements and vitamins. This addition reflects the rapid growth of the dietary supplement market, driven by increasing consumer demand for products that support overall health and wellness.
